Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).

“To modernize our patent infrastructure, we need better tools to help inventors and examiners find relevant prior art.” Patent categories were established more than 100 years ago. There are dozens of ...

The US National Vegetation Classification (USNVC) provides a national, conceptual framework for classifying, inventorying, and studying both cultural and natural vegetation of the U.S. It provides a ...

The European Association of Dermato-Oncology (EADO) classification system identified difficult-to-treat tumours in transplant patients with cutaneous squamous cell carcinoma (cSCC) on the basis of ...